Service-Tutorial-Lab near Hanover MB (40 Result(s))

The Life Science Association of Manitoba (LSAM) is the voice and organizational nucleus for the life science industry of Manitoba.This innovative industry, which now accounts for nearly 7% of Manitoba's GDP, is extremely diverse and wide-reaching.The life science industry's core businesses can be grouped in three distinct categories: Agriculture and Food, Health, Industrial BioProducts, LSAM focuses on attentive, proactive and timely services and programs to over 90 member organizations. We constantly strive to understand which products, services and support our members value most, and create partnerships and programs to deliver them.

We know you want to focus on your client - not tracking down paperwork or following up on missing signatures. With ExamOne managing your application process, you can rest assured that your applicants' experience is enjoyable and professional. And with our innovative scheduling system, convenient appointment options and laboratory integration, your policy delivery cycle will be faster than ever

7% of Canadians have Macular DegenerationBy 2030, over 20% of Canadians will have Macular Degeneration1 in 9 of those over 65 have reduced visionResearch studies tell us that individuals who are legally blind would give up 60% of their remaining lifespan to see again1 in 4 of those over 80 have a vision impairmentEye Canada 2009 Helping You See BetterFocusing on Low Vision Care in Canada 2-1200 Waverley Street, Winnipeg, Manitob,a Canada

We are a locally-owned and operated eye health group with two locations in Winnipeg. Our eye health group employs six Doctors of Optometry (ODs) who provide primary vision care. This includes vision correction, as well as the diagnosis and treatment of various eye conditions. A referral to an ophthalmologist is provided when necessary for treatment of eye diseases. We also diagnose and monitor systemic diseases such as hypertension and diabetes (which often first appear in the eye). Each location is equipped with a full-service optical dispensary, supported by technicians and optometric assistants ready to meet your vision needs.

Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.

Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.